Email: marion.zibelli@bairdscmc.com
Linkedin: marion-zibelli
Telephone: +34 607 029 780

Marion Zibelli started her career by supervising the design and implementation of the first advocacy programme on new preventive technologies for HIV/AIDS ever developed in Spain. The program was designed to introduce new preventive options to respond to HIV/AIDS to other NGOs, the media, members of the Parliament and all-level government officials in Spain. She specializes in HIV/AIDS and has worked on a range of private and not for profit studies and initiatives to promote AIDS vaccines, microbicides, pre- and post-exposure prophylaxis (including injectable PrEP), and secure advance market commitments.

Experience

In collaboration with Baird’s CMC Marion has produced intelligence and strategic guidance for both not for profit organisations and pharmaceutical companies to accelerate approvals and facilitate access to new pharmaceuticals and vaccines worldwide. She has also coordinated national research as part of larger international market entry and development studies, stakeholder mapping exercises and perception studies for communication strategy for both private and non-for-profit sectors. Her experience includes

• a study on vaccine approval and reimbursement processes in Spain and international study on vaccines access and uptake
• comprehensive HCV stakeholder mapping on HCV treatment provision in Spain and Latin America
• producing strategic guidance on third-party engagement on HIV/AIDS
• providing support for national level policy, advocacy and communication activities in Spain, to the Bill and Melinda Gates Foundation
• support for GAVI new donors project
• study on potential and future introduction of injectable PrEP

Expertise

Marion has 15 years experience in global health policy and advocacy, working especially in Spain but also focusing on European and emerging markets, and specializing in strategies, public relations, alliance building, and community mobilization. She has a sound understanding of the complexity of scientific research and the opportunities and challenges it brings to development. Her expertise includes

• communication strategy
• public relations
• policy communications
• scientific communications
• government relations
• community mobilization and alliance building

Clients

• International AIDS Vaccine Initiative (IAVI)
• International Partnership for Microbicides (IPM)
• Global Advocacy for HIV Prevention (AVAC)
• Aeras
• FIND Diagnostics
• Global Alliance for TB Drug Development (TB Alliance)
• Bill and Melinda Gates Foundation
• GAVI Alliance
• Pharmaceutical companies including Sanofi, Novartis, Pfizer, ViiV & BMS

Roles

• Associate at Baird’s CMC
• Independent Consultant

[/vc_column_text][/vc_column][/vc_row]